ArticleNature communications2024

The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial.

Ehsan Malek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.